Stereotaxis, Inc. (STXS) financial statements and ratios from SEC XBRL: revenue $32.38M (TTM), net margin -66.8%, revenue growth -15.8% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $32.38M |
| Net Margin | -66.8% |
| Revenue Growth (YoY) | -15.8% |
| EPS Growth (YoY) | -14.3% |
| Price / Book | 9.84 |
| Price / Sales | 4.53 |
| FCF Yield | -8.1% |
| Altman Z-Score | -13.97 (distress) |
| Sector P/E (Healthcare) | 21.6 |
STXS overview · STXS earnings · STXS KPIs · STXS investor relations · STXS ownership · STXS peers · STXS filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.